AGS.BR vs. ABBV
AGS.BR (Ageas) and ABBV (AbbVie Inc.) are both stocks. AGS.BR operates in Insurance - Diversified (Financial Services), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, AGS.BR returned 12.72%/yr vs 18.07%/yr for ABBV. At a 0.10 correlation, their price movements are largely independent.
Performance
AGS.BR vs. ABBV - Performance Comparison
Loading charts...
Different Trading Currencies
AGS.BR is traded in EUR, while ABBV is traded in USD. To make them comparable, the ABBV values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, AGS.BR achieves a 9.67% return, which is significantly higher than ABBV's 1.20% return. Over the past 10 years, AGS.BR has underperformed ABBV with an annualized return of 12.72%, while ABBV has yielded a comparatively higher 18.07% annualized return.
AGS.BR
- 1D
- -0.63%
- 1M
- -2.55%
- YTD
- 9.67%
- 6M
- 15.26%
- 1Y
- 19.14%
- 3Y*
- 26.87%
- 5Y*
- 12.49%
- 10Y*
- 12.72%
ABBV
- 1D
- 0.00%
- 1M
- 10.97%
- YTD
- 1.20%
- 6M
- 1.36%
- 1Y
- 22.08%
- 3Y*
- 19.42%
- 5Y*
- 20.39%
- 10Y*
- 18.07%
AGS.BR vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AGS.BR Ageas | 9.67% | 35.60% | 28.07% | 2.73% | 0.55% | 9.92% | -10.45% | 40.91% | 1.18% | 14.65% |
ABBV AbbVie Inc. | 3.06% | 17.29% | 26.71% | -3.23% | 31.69% | 42.33% | 17.19% | 3.76% | 3.69% | 40.40% |
Correlation
The correlation between AGS.BR and ABBV is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.01 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.10 |
The correlation between AGS.BR and ABBV shifts across timeframes, from -0.05 (3 years) to 0.10 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGS.BR vs. ABBV — Risk / Return Rank
AGS.BR
ABBV
AGS.BR vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ageas (AGS.BR) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AGS.BR | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.27 | ||
| Sortino ratioReturn per unit of downside risk | +0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.18 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.08 | 1.29 | +0.79 |
| Martin ratioReturn relative to average drawdown | 4.22 | 2.98 | +1.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AGS.BR | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.20 | 0.93 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.54 | 0.86 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | 0.68 | -0.19 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.76 | -0.76 |
Drawdowns
AGS.BR vs. ABBV - Drawdown Comparison
The maximum AGS.BR drawdown since its inception was -97.90%, which is greater than ABBV's maximum drawdown of -38.52%. Use the drawdown chart below to compare losses from any high point for AGS.BR and ABBV.
Loading charts...
Drawdown Indicators
| AGS.BR | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.90% | -38.52% | -59.38% |
Max Drawdown (1Y)Largest decline over 1 year | -9.54% | -17.22% | +7.68% |
Max Drawdown (3Y)Largest decline over 3 years | -13.29% | -26.03% | +12.74% |
Max Drawdown (5Y)Largest decline over 5 years | -23.55% | -26.03% | +2.48% |
Max Drawdown (10Y)Largest decline over 10 years | -53.78% | -38.52% | -15.26% |
Current DrawdownCurrent decline from peak | -37.45% | -4.81% | -32.64% |
Average DrawdownAverage peak-to-trough decline | -61.96% | -9.23% | -52.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.61% | 7.42% | -2.81% |
Volatility
AGS.BR vs. ABBV - Volatility Comparison
The current volatility for Ageas (AGS.BR) is 4.07%, while AbbVie Inc. (ABBV) has a volatility of 6.53%. This indicates that AGS.BR experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGS.BR | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.07% | 6.53% | -2.46% |
Volatility (6M)Calculated over the trailing 6-month period | 13.56% | 17.62% | -4.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.60% | 23.91% | -7.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.64% | 23.72% | -1.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.24% | 26.47% | -1.23% |
Dividends
AGS.BR vs. ABBV - Dividend Comparison
AGS.BR's dividend yield for the trailing twelve months is around 5.92%, more than ABBV's 2.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.97% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
AGS.BR Ageas | 5.92% | 5.85% | 6.93% | 7.63% | 10.26% | 5.82% | 6.08% | 4.18% | 5.34% | 5.16% | 4.39% | 3.60% |
Financials
AGS.BR vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Ageas and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AGS.BR and ABBV have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AGS.BR and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer